DEVELOPICK
LIVE

Serial Number

79365404

Owner

Samsung Biologics Co., Ltd.

Attorney

Brian P. Gregg

Filing Date

Jan 31, 2023

Add to watchlist:

No watchlists yet
View on USPTO

DEVELOPICK Trademark

Serial Number: 79365404 • Registration: 7539787

DEVELOPICK is a trademark filed by Samsung Biologics Co., Ltd. on January 31, 2023. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Samsung Biologics Co., Ltd. (26 trademarks)

300, Songdo bio-daero,

Entity Type: 03

Trademark Details

Filing Date

January 31, 2023

Registration Date

October 22, 2024

Published for Opposition

August 6, 2024

Goods & Services

Custom manufacture of polyclonal antibodies for pharmaceutical use; custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; processing of plant hormones being phytohormones; processing of medicinal materials; processing of pharmaceutical preparations; custom manufacture of pharmaceuticals; processing of pharmaceuticals; custom manufacture of pharmaceutical bispecific antibodies; processing of chemical reagents

Advisory services relating to technological research in the field of pharmaceutical manufacturing processes; advisory services relating to scientific analysis in the field of nucleic acids; research relating to science, namely, scientific research; conducting of technical feasibility studies, namely, conducting of feasibility studies in the field of new technologies; multiple nucleic acid scientific analysis; multiple nucleic check, namely, materials testing; analysis of materials; materials testing and evaluation; chemical analysis services for use in the testing of material; molecular analysis, namely, scientific analysis in the field of molecular biology; advisory services relating to biotechnology; technical management advisory services relating to biotechnology, namely, scientific research consulting, biotechnology consultancy services; biochemical analysis; advisory services relating to biochemistry research; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; design of new products for others; technical advice relating to safety, namely, consumer product safety testing consultation; pharmaceutical research and development; pharmaceutical products evaluation; clinical research in the field of medicines; services for assessing the efficiency of pharmaceuticals, namely, testing of pharmaceuticals; testing of raw materials; fusion protein analysis being testing of raw materials; computer programming services in the medical field; computer project management services relating to imaging medical data; medicine research being medical research; scientific analysis and quality evaluation of medical product development; pharmaceutical technology advisory service, namely, computer technology consultancy; pharmaceutical product evaluation; providing scientific and medical information on the testing, inspection and research of medical products; pharmaceutical product evaluation; scientific laboratory services relating to the production of bispecific antibody; bispecific antibody drug development; double antibody reagent scientific research and development; evaluating of clinical trial progress, namely, conducting clinical trials for others; clinical research, namely, conducting clinical trials for others; evaluation of product development being product quality evaluation; product safety testing; quality assurance consultancy in the field of pharmaceuticals; quality assessment being product testing; scientific research advisory services relating to chemical reagents; evaluation of chemical syntheses being product quality evaluation

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 12, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 25, 2025 FICS
FINAL DISPOSITION PROCESSED
Mar 25, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 22, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 22, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 22, 2024 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 31, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 14, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 14, 2024 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 6, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 6, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 17, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 1, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 14, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 14, 2024 CRFA
ASSIGNED TO LIE
Jun 14, 2024 ALIE
NOTICE OF REVIVAL - E-MAILED
May 14, 2024 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 14, 2024 TROA
PETITION TO REVIVE-GRANTED
May 14, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
May 14, 2024 PROA
REFUSAL PROCESSED BY IB
Nov 22, 2023 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 2, 2023 RFCS
REFUSAL PROCESSED BY MPU
Nov 2, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 2, 2023 RFCR
NON-FINAL ACTION WRITTEN
Nov 1, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 30, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 21, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 17, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 16, 2023 REPR